Name (Synonyms) | Correlation | |
---|---|---|
drug186 | Biological: mRNA-1273: 100 mcg Wiki | 1.00 |
drug820 | Mesenchymal Stromal Cells Wiki | 0.58 |
drug1016 | Placebo Wiki | 0.08 |
Name (Synonyms) | Correlation | |
---|---|---|
D013577 | Syndrome NIH | 0.13 |
D055371 | Acute Lung Injury NIH | 0.12 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.12 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.10 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This clinical study will assess the safety, reactogenicity, and immunogenicity of 2 dose levels of mRNA-1273 SARS-COV-2 vaccine in adults 18 years of age or older.
Description: Seroconversion as measured by an increase of SARS-CoV-2-specific neutralizing antibody (nAb) titer either from below the limit of detection (LOD) or lower limit of quantification (LLOQ) to equal to or above LOD or LLOQ, or a 4-times higher titer in participants with pre-existing nAb titers.
Measure: Seroconversion as measured by an increase of SARS-CoV-2-specific neutralizing antibody (nAb) titer Time: Through 1 year post last vaccination